India’s first fertility-services company IPO hits the market
The much-anticipated Gaudium IVF & Women Health IPO is finally here — and it’s grabbing attention because this is one of the first companies focused on in-vitro fertilisation (IVF) and reproductive health to tap the public markets in India. (IPOUPDATES)
📅 IPO Timeline & Key Dates
| Event | Date |
|---|---|
| IPO Opens for Subscription | 20 February 2026 |
| IPO Closes | 24 February 2026 |
| Allotment Finalised | 25 February 2026 |
| Shares Credited to Demat | 26 February 2026 |
| Listing on NSE & BSE | 27 February 2026 |
👉 The company has set a fixed schedule from subscription to listing, meaning investors will know allotment outcomes within a few days of the IPO closing.
💰 Issue Structure & Price Band
The IPO consists of two parts:
✔️ Fresh Issue – New shares issued by the company to raise capital
✔️ Offer For Sale (OFS) – Shares sold by existing shareholders
Breakdown
- Fresh Issue: ~1.13 crore equity shares
- OFS by Promoter: ~94.93 lakh shares
- Total Issue Size: ~2.07 crore shares
- Face Value: ₹5 per share
- Price Band: Awaited/Not yet declared
- Listing Exchanges: BSE & NSE
- Retail Quota: ~35%
- QIB Quota: ~50%
- HNI (NII) Quota: ~15%
📌 Note: The exact price band and lot size will be announced shortly before the IPO opens.
🏥 Company Overview — Who Is Gaudium IVF?
Gaudium IVF & Women’s Health Ltd. is an Indian health-care company operating in the fertility and reproductive health sector.
What It Does
- Offers in-vitro fertilisation (IVF) treatment and related reproductive services
- Includes advanced procedures such as ICSI, IUI, ovulation induction, and male fertility care
- Uses a hub-and-spoke model — large centres (hubs) supported by smaller referral spokes
- Works in 30+ cities across India
- Caters to domestic patients and international medical tourism clients
Founded by fertility specialist Dr. Manika Khanna, the company has grown over the years to become one of the most recognised IVF service providers in the country.
📊 Financial Snapshot
Gaudium IVF has shown steady financial growth, with rising revenues and profits in recent years:
- Revenue (FY 2025): ₹70.72 crore
- Profit After Tax: ₹19.13 crore
- Revenue and profit grew significantly compared to the previous year.
This growth underscores rising demand for fertility services in India, driven by increasing awareness and expanding medical capabilities.
📈 Planned Use of IPO Proceeds
The company plans to use new funds for:
🔹 Capital expenditure — Opening 19 new IVF centres throughout India
🔹 Debt repayment/reduction
🔹 General corporate purposes
Expanding into underserved regions is a major part of the growth strategy.
📍 Why This IPO Matters
📌 Sector First
This marks one of the first Indian companies in the fertility and assisted reproductive technology space to go public, giving retail investors a chance to participate in a new healthcare theme.
📌 Growing Market
Industry reports project India’s IVF and ART (assisted reproductive technology) market to grow rapidly in the coming years, driven by rising infertility rates and increased access to advanced reproductive care. (The Economic Times Hindi)
🧠 Grey Market & Pricing Expectations
Before the official price band is fixed, brokers and market trackers estimate an unofficial “Grey Market Premium” (GMP) — a measure of anticipated listing gains.
👉 For this IPO, the GMP has fluctuated, with some estimates suggesting modest or even discounted listing expectations.
⚠️ Important: These are unofficial estimates and should not be taken as investment advice.
📉 Risks & Things to Consider
Before applying for any IPO, especially healthcare stocks:
🔸 Price band unknown — without it, valuation expectations are unclear.
🔸 Listing gains not guaranteed — GMPs are unofficial.
🔸 Healthcare services stocks may take time to grow depending on policies, competition, and demand.
🔸 Apply based on long-term view, not short-term listing gains.
📌 How to Apply
You can apply for the IPO through:
- Banking apps (UPI IPO section)
- Brokerage platforms (Zerodha, Groww, etc.)
- Demat account service providers
Usually, retail investors bid for IPOs at the cut-off price to improve chances of allotment.
🏢 Company Office (Registered & Corporate Office)
Gaudium IVF & Women Health Ltd.
📍 Address: B1/51, Janakpuri East (Near Janakpuri East Metro Station),
New Delhi – 110058, India
📞 Phone: +91-85278-58585 / 011-4885-8585
📧 Email: info@gaudiumivfcentre.com (general)
📧 Compliance/Investor Email: compliance@gaudiumivfcentre.com
🌐 Website: https://www.gaudiumivfcentre.com/
💡 They also have other centres in India — like in Kailash Colony (South Delhi), Mumbai, Bengaluru, Patna, Ludhiana, and Srinagar — mainly for clinical services, but the New Delhi address above is the main corporate and registered office.
📇 Registrar for IPO – Bigshare Services Pvt. Ltd.
The Registrar & Transfer Agent (RTA) handles IPO allotments, investor queries, and related investor services:
📍 Bigshare Services Pvt. Ltd. – Mumbai Office
Office No. S6-2, 6th Floor, Pinnacle Business Park,
Mahakali Caves Rd, next to Ahura Centre,
Andheri (East), Mumbai – 400093, India
📞 Phone: +91-22-6263 8200
📧 Emails:
- investor@bigshareonline.com
- ipo@bigshareonline.com
🌐 Registrar Website: https://ipo.bigshareonline.com/IPO_Status.html
📌 Bigshare also has regional offices (e.g., Delhi and Ahmedabad) if you need in-person support, but the Mumbai office above is the primary RTA hub.MER
DISCLAMER
DISCLAMERThe information shared here is intended solely for educational and general awareness purposes. Any securities, investments, or IPO-related details mentioned should not be interpreted as financial advice or investment recommendations. Readers are encouraged to conduct their own independent research or seek guidance from a qualified financial professional before making investment decisions.
IPO-related updates are provided for informational use only. Market trends, past performance, or investor interest do not ensure future outcomes. We are not registered with SEBI. Investments in IPOs and the securities market involve inherent risks, and individuals should carefully evaluate their financial situation or consult a certified financial advisor before investing.
